RNA Interference-based Therapies for the Reduction of Cardiovascular Risk
Nazarenko N, Seo J, Nagraj S, Palaiodimos L, Kokkinidis D. RNA Interference-based Therapies for the Reduction of Cardiovascular Risk. Current Molecular Pharmacology 2024, 17: e18761429264553. PMID: 38449067, DOI: 10.2174/0118761429264553231204115314.Peer-Reviewed Original ResearchLDL-C levelsLDL-CReduction of cardiovascular riskRNA interference-based therapiesSignificant cardiovascular eventsLDL-C level reductionRisk of cardiovascular diseaseCases of coronary artery diseaseNon-modifiable risk factorsCoronary artery diseasePrevalent risk factorIncidence of CVDLowering lipid levelsRisk factors of heart diseaseCardiovascular eventsFactors of heart diseaseMortality benefitCardiovascular riskArtery diseaseRisk factorsHeart diseaseLipid levelsCardiovascular diseasePrevent 2Lifestyle factors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply